Press Releases from Reapplix (4 total)
REAPPLIX RECEIVES CODING AND REIMBURSEMENT DETAILS FOR 3C PATCH® IN THE US
3C Patch® https://3cpatch.com/ is a first-in-class advanced biologic autologous cell therapy targeting hard-to-heal diabetic foot ulcers
(Birkerod, Denmark) – Reapplix, a privately-held, regenerative medicine company today…
A FINAL MEDICARE NATIONAL COVERAGE DETERMINATION HAS BEEN PUBLISHED ENABLING SUS …
Commercialization of this unique, breakthrough treatment for diabetic foot ulcers to be accelerated in the United States
(Birkerod, Denmark) – Reapplix announces that a final National…
REAPPLIX ANNOUNCES APPOINTMENT OF RICHARD TWOMEY TO BOARD OF DIRECTORS
Reapplix is very pleased to be able to announce that Richard Twomey has been appointed to the Board of Directors. Mr. Twomey is a highly…
REAPPLIX RECEIVES NEW REIMBURSEMENT CODING AND COMPLETES USD 22.6M EQUITY FINANC …
Reapplix announces that it has successfully received Medicare reimbursement coding instructions from the Centers for Medicare and Medicaid Services (CMS) with a national average payment…
Go To Page:
